Viruses survive often harsh host environments, yet we know little about the strategies they
utilize to adapt and subsist given their limited genomic resources. We are beginning to …

How viruses enter cells is of critical importance to pathogenesis in the host and for treatment
strategies. Over the last several years, the herpesvirus field has made numerous and …

Epstein-Barr virus (EBV) and Kaposi's sarcoma-associated herpesvirus (KSHV) are
classified into the gammaherpesvirus subfamily of Herpesviridae, which stands out from its …

Kaposi's sarcoma-associated herpesvirus (KSHV) is an oncogenic gammaherpesvirus that
can replicate in oral epithelial cells to promote viral transmission via saliva. To identify novel …

Assembly of Kaposi's sarcoma-associated herpesvirus (KSHV) begins at a bacteriophage-
like portal complex that nucleates formation of an icosahedral capsid with capsid-associated …

Kaposi's sarcoma-associated herpesvirus (KSHV) protein ORF45 is a virion-associated
tegument protein that is unique to the gammaherpesvirus family. Generation of KSHV …

Kaposi sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus-8, is the
causal agent of Kaposi sarcoma, a cancer that appears as tumors on the skin or mucosal …

Alpha herpesvirus genomes encode the capacity to establish quiescent infections (ie
latency) in the peripheral nervous system for the life of their hosts. Multiple times during …

As the first discovered human cancer virus, Epstein–Barr virus (EBV) causes Burkitt's
lymphoma and nasopharyngeal carcinoma. Isolating virions for determining high-resolution …

The process of Kaposi's Sarcoma Herpes Virus'(KSHV) entry into target cells is complex and
engages several viral glycoproteins which bind to a large range of host cell surface …